Previous 10 | Next 10 |
Co-Diagnostics (NASDAQ:CODX) enters into definitive agreements with Idaho Molecular and Advanced Conceptions, pursuant to which each of them will become wholly-owned subsidiaries of CODX. The deals will provide CODX with all existing and future assets and intellectual property related to the ...
Co-Diagnostics, Inc. Signs Agreement to Acquire all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform Definitive merger agreements provide the Company with all existing and future assets, future product iterations, and intellectual property rights of the...
Teleflex Incorporated has generally performed well over the past few years and that attractive performance resumed this year after a mixed 2020. The company's prospects are favorable, but this doesn't mean the company makes for a great buy today. In all, shares are probably more o...
Co-Diagnostics (CODX +2.8%) is partnering with Tiicker, a platform and app that rewards shareholder loyalty, to reach more potential investors. Tiicker is designed to connect with an individual's online brokerage account and then provide discounts, upgrades, swag, and the like on products tha...
Creator of COVID-19 and Global Molecular Testing Products Co-Diagnostics, Inc. Launches Retail Investor and Perks Program with TiiCKER Innovative testing technology stock leverages TiiCKER artificial intelligence-driven platform to engage, verify and reward shareholders PR N...
Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for ABC Multiplex Test PR Newswire SALT LAKE CITY , Dec. 7, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented pl...
Co-Diagnostics (NASDAQ:CODX) says that the mutations found in the new Omicron COVID-19 variant do not impact the company's COVID-19 tests' ability to provide accurate results. Shares are up 6% in premarket trading. The company said that it examined the effectiveness of its COVID-19 ...
Krystal Biotech KRYS +115% says study on VYJUVEKTM for rare skin disease met primary endpoint Petros Pharmaceuticals PTPI +62% 180 Life Sciences, Vaxart gain amid social media buzz; Petros climb over 60% NRx Pharmaceuticals NRXP +48% after Zyesami increased likel...
Co-Diagnostics, Inc. Reports that Suite of COVID-19 Diagnostics Not Affected by Heavily Mutated Omicron Variant PR Newswire SALT LAKE CITY , Nov. 29, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a ...
iSpecimen (NASDAQ:ISPC) +70% COVID-19 vaccine stocks surge on worries over new variant Allied Healthcare Products (NASDAQ:AHPI) +68%. Alpha Pro Tech (NYSE:APT) +24% Zoom Video and Peloton take off as new COVID variant revives stay-at-home trade Valneva SE (NASDAQ:VALN) +18...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...